DaShenLin Pharmaceutical Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002RG2
  • SHG: 603233
CNY
17.97
0.22 (1.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
DaShenLin Pharmaceutical Group Co., Ltd.

Why is DaShenLin Pharmaceutical Group Co., Ltd. ?

1
The company has declared Positive results for the last 5 consecutive quarters
  • ROCE(HY) Highest at 18.11%
  • INVENTORY TURNOVER RATIO(HY) Highest at 4.59 times
  • RAW MATERIAL COST(Y) Fallen by -2.39% (YoY)
2
With ROE of 18.30%, it has a attractive valuation with a 2.14 Price to Book Value
  • Over the past year, while the stock has generated a return of 4.66%, its profits have risen by 39.6% ; the PEG ratio of the company is 0.3
  • At the current price, the company has a high dividend yield of 5.6
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to DaShenLin Pharmaceutical Group Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is DaShenLin Pharmaceutical Group Co., Ltd. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
DaShenLin Pharmaceutical Group Co., Ltd.
5.03%
-0.25
33.62%
China Shanghai Composite
3.0%
0.22
14.72%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
12.51%
EBIT Growth (5y)
7.50%
EBIT to Interest (avg)
7.52
Debt to EBITDA (avg)
0.89
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
1.58
Tax Ratio
26.34%
Dividend Payout Ratio
76.07%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
16.28%
ROE (avg)
16.57%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
2.14
EV to EBIT
9.67
EV to EBITDA
5.86
EV to Capital Employed
1.83
EV to Sales
0.72
PEG Ratio
0.30
Dividend Yield
5.60%
ROCE (Latest)
18.87%
ROE (Latest)
18.30%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
ROCE(HY)

Highest at 18.11%

INVENTORY TURNOVER RATIO(HY)

Highest at 4.59 times

RAW MATERIAL COST(Y)

Fallen by -2.39% (YoY

CASH AND EQV(HY)

Highest at CNY 13,349.92 MM

DEBT-EQUITY RATIO (HY)

Lowest at 71.7 %

DIVIDEND PER SHARE(HY)

Highest at CNY 13.86

-2What is not working for the Company
INTEREST(Q)

At CNY 43.73 MM has Grown at 24.72%

Here's what is working for DaShenLin Pharmaceutical Group Co., Ltd.

Inventory Turnover Ratio
Highest at 4.59 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Cash and Eqv
Highest at CNY 13,349.92 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio
Lowest at 71.7 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Dividend per share
Highest at CNY 13.86
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (CNY)

Raw Material Cost
Fallen by -2.39% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for DaShenLin Pharmaceutical Group Co., Ltd.

Interest
At CNY 43.73 MM has Grown at 24.72%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Footer loading